00000nam 2200000za 4500 9.833924 CaOODSP 20221107150324 cr ||||||||||| 170427s2017 onc ob f000 0 eng d 978-0-660-08010-9 CaOODSP eng n-cn--- HP40-177/2017E-PDF Canadian HIV Vaccine Initiative achievements report [electronic resource]. Ottawa : Public Health Agency of Canada, 2017. i, 29 p. Issued also in French under title: Rapport des réalisations Initiative canadienne de vaccin contre le VIH. Cover title. "Publication date: March 2017"--Verso of cover. Includes bibliographical references. "The Canadian HIV Vaccine Initiative (CHVI), which concludes in March 2017, has been a unique collaboration between the Government of Canada (GoC) (the Public Health Agency of Canada (PHAC); Health Canada (HC); the Canadian Institutes of Health Research (CIHR); Innovation, Science and Economic Development (ISED); the National Research Council (NRC); and Global Affairs Canada (GAC)) and the Bill & Melinda Gates Foundation (BMGF) to further strengthen global efforts to accelerate the development of a safe, effective, affordable and globally accessible HIV vaccine. An investment of $139M (GoC - $111M from existing resources; BMGF - $28M) was made to support CHVI activities since 2007, a small investment considering that, in 2009, the total costs of HIV in Canada (loss of quality of life, health care costs, and productivity loss) was estimated at just over $4 billion. Overall, CHVI activities served to advance global research and development (R&D) on HIV vaccine research and other HIV-related research, and to increase the visibility of Canadian HIV vaccine research, both domestically and internationally … "--Executive summary, p. 1. gccst AIDS (disease) gccst Immunization gccst Research and development Public Health Agency of Canada. Rapport des réalisations Initiative canadienne de vaccin contre le VIH (CaOODSP)9.833925 PDF 351 KB https://publications.gc.ca/collections/collection_2017/aspc-phac/HP40-177-2017-eng.pdf 160352